Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 15Prostatic Neoplasms 3Neoplasms, Hormone-Dependent 3Carcinoma, Lobular 3Carcinoma, Ductal, Breast 3Prostatic Intraepithelial Neoplasia 2Fractures, Bone 2Desmoid Tumors 2Triple Negative Breast Neoplasms 1Recurrence 1Precancerous Conditions 1Ovarian Neoplasms 1Osteoporosis 1Neoplasms 1Neoplasm Metastasis 1Hormone-receptor-positive Breast Cancer 1Carcinoma, Ovarian Epithelial 1Breast Carcinoma In Situ 1Breast Cancer Patients in Premenopausal 1Breast Cancer Organoids 1Bone Diseases, Metabolic 1

Interventions

Zoledronic Acid 4Denosumab 4Toremifene 2Aromatase Inhibitors 2radium Ra 223 dichloride 1Vitamin D 1Tobacco Products 1Propofol 1Neuroleptanalgesia 1Midazolam 1Letrozole 1Hormone Replacement Therapy 1Heart Disease Risk Factors 1Exercise 1Etomidate 1Ethanol 1Cholecalciferol 1Cari-D-Tect 1Aspirin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fractures, Bone × Toremifene × Clear all
NCT00129142 2013-11-15

Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy

GTx

Phase 3 Completed
1,200 enrolled
Genitourinary

Bone Diseases, Metabolic, Osteoporosis, Prostatic Neoplasms, Fractures, Bone

NCT01214291 2013-11-15

TREAT2

GTx

Phase 3 Withdrawn
Genitourinary

Prostatic Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡